tag smc 
Pharmaceutical Technology
FEBRUARY 10, 2023
This is not the first treatment to come with a high price tag. On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5
pharmaphorum
NOVEMBER 19, 2021
million price tag make it is the most expensive treatment ever approved for NHS funding. Meanwhile, in Scotland, the drug is currently under evaluation by the Scottish Medicines Consortium (SMC) with a verdict expected in early 2022. The post NICE reaches a deal with Roche on access to oral SMA drug Evrysdi appeared first on.
pharmaphorum
NOVEMBER 16, 2021
“We look forward to the full technology appraisal guidance (TAG) which is due to be published in early December 2021,” he added. An opinion from the Scottish Medicine Consortium (SMC) on the use of the drug by NHS Scotland is expected to be published early in 2022.
Expert insights. Personalized for you.
263 
Let's personalize your content